Kerry Rodabaugh

Author PubWeight™ 11.59^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer.	Proc Natl Acad Sci U S A	2007	2.61
2	Phase I study of abagovomab in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer.	Clin Cancer Res	2006	1.48
3	Adjuvant vaginal brachytherapy alone for high risk localized endometrial cancer as defined by the three major randomized trials of adjuvant pelvic radiation.	Gynecol Oncol	2009	1.02
4	Higher regular coffee and tea consumption is associated with reduced endometrial cancer risk.	Int J Cancer	2009	0.91
5	SCP-1 cancer/testis antigen is a prognostic indicator and a candidate target for immunotherapy in epithelial ovarian cancer.	Cancer Immun	2004	0.89
6	A-kinase anchoring protein 3 messenger RNA expression correlates with poor prognosis in epithelial ovarian cancer.	Gynecol Oncol	2005	0.88
7	Role of prophylactic hysterectomy in patients at high risk for hereditary cancers.	Gynecol Oncol	2006	0.81
8	Desmoplastic small round cell tumor (DSRCT) with ovarian involvement in 2 young women.	Appl Immunohistochem Mol Morphol	2008	0.79
9	Blueprint for success: translating innovations from the field of palliative medicine to the medical-legal partnership.	J Leg Med	2014	0.78
10	Response of combination platinum and gemcitabine chemotherapy for recurrent epithelial ovarian carcinoma.	Gynecol Oncol	2004	0.76
11	Intraobserver and interobserver variability in distinguishing between endocervical and endometrial adenocarcinoma on problematic cases of cervical curettings.	Int J Gynecol Pathol	2008	0.75
12	Analysis of the time interval between diagnoses in women with double primary breast and ovarian or primary peritoneal cancers.	Gynecol Oncol	2004	0.75